Salt Hill agrees exclusive patent license from Queen Mary University of London to advance novel Treg activation technology
27th October 2025
We recognise that the root cause of many of the world’s neglected diseases is pathological inflammation. We are uniquely positioned to address this.
Our pioneering approach prioritises generating human data through running expedited mechanistic studies. These studies take our fundamental understanding of disease to inform therapeutic application.
